Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

1.

A novel approach to delayed-start analyses for demonstrating disease-modifying effects in Alzheimer's disease.

Liu-Seifert H, Andersen SW, Lipkovich I, Holdridge KC, Siemers E.

PLoS One. 2015 Mar 17;10(3):e0119632. doi: 10.1371/journal.pone.0119632. eCollection 2015.

2.

Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics.

Liu-Seifert H, Ascher-Svanum H, Osuntokun O, Jen KY, Gomez JC.

BMC Psychiatry. 2011 May 17;11:87. doi: 10.1186/1471-244X-11-87.

3.

Patient perspectives on antipsychotic treatments and their association with clinical outcomes.

Liu-Seifert H, Osuntokun OO, Godfrey JL, Feldman PD.

Patient Prefer Adherence. 2010 Oct 5;4:369-77.

4.

A closer look at the baseline-observation-carried-forward (BOCF).

Liu-Seifert H, Zhang S, D'Souza D, Skljarevski V.

Patient Prefer Adherence. 2010 Feb 4;4:11-6.

5.

Predictors of premature discontinuation of treatment in multiple disease states.

Nantz E, Liu-Seifert H, Skljarevski V.

Patient Prefer Adherence. 2009 Nov 3;3:31-43.

6.

Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone.

Liu-Seifert H, Kinon BJ, Tennant CJ, Sniadecki J, Volavka J.

Neuropsychiatr Dis Treat. 2009;5:47-54. Epub 2009 Apr 8.

7.

Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia.

Liu-Seifert H, Adams DH, Ascher-Svanum H, Faries DE, Kinon BJ.

Patient Prefer Adherence. 2007 Dec 20;1:9-17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk